Tvardi Therapeutics (TVRD) Earnings Analysis
Tvardi Therapeutics (TVRD) next reports earnings on 2026-08-13, consensus EPS -0.70444 USD. Last quarter (2026-05-08) it missed with EPS -0.73 USD vs -0.65 USD est (-12.3%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -1.74.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TVRD next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.70444 USD |
| Revenue estimate | n/a |
TVRD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | -0.73 USD | -0.65 USD | -12.3% | Miss |
| 2026-03-31 | -0.78 USD | -0.55 USD | -41.8% | Miss |
| 2025-11-13 | -0.59 USD | -0.83 USD | +28.9% | Beat |
| 2025-08-14 | -1 USD | -0.51 USD | -96.1% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
TVRD valuation and analyst view
| Trailing P/E | -1.74 |
|---|---|
| Trailing EPS | -1.64571 USD |
| Price / book | 1.79 |
| Dividend yield | 0.00% |
| Market cap | 0.03B |
| Analyst consensus | Buy (2 buy / 1 hold / 1 sell) |
| Avg price target | 10.67 USD |
Related research pages
Frequently asked questions
When is Tvardi Therapeutics (TVRD)'s next earnings date?
Tvardi Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.70444 USD.
Did TVRD beat earnings last quarter?
In its 2026-05-08 report, TVRD posted EPS of -0.73 USD versus a -0.65 USD estimate — a miss of 12.3%.
What is TVRD's earnings track record?
Over the last 4 reported quarters with consensus data, TVRD beat estimates 1 times (25%).
What is TVRD's current P/E ratio and EPS?
TVRD trades at a trailing P/E of -1.74 on trailing EPS of -1.645713023634993 USD.
What do analysts rate TVRD?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell). Average 12-month price target: 10.67 USD.